| SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ... Nature 599 (7883), 114-119, 2021 | 1228 | 2021 |
| SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021 | 917 | 2021 |
| Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity B Meng, A Abdullahi, IATM Ferreira, N Goonawardane, A Saito, I Kimura, ... Nature 603 (7902), 706-714, 2022 | 832 | 2022 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 696 | 2021 |
| Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 DA Collier, IATM Ferreira, P Kotagiri, RP Datir, EY Lim, E Touizer, B Meng, ... Nature 596 (7872), 417-422, 2021 | 646 | 2021 |
| Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission L Rivett, S Sridhar, D Sparkes, M Routledge, NK Jones, S Forrest, ... elife 9, e58728, 2020 | 595 | 2020 |
| A thermostable, closed SARS-CoV-2 spike protein trimer X Xiong, K Qu, KA Ciazynska, M Hosmillo, AP Carter, S Ebrahimi, Z Ke, ... Nature structural & molecular biology 27 (10), 934-941, 2020 | 278 | 2020 |
| Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease L Bergamaschi, F Mescia, L Turner, AL Hanson, P Kotagiri, BJ Dunmore, ... Immunity 54 (6), 1257-1275. e8, 2021 | 265 | 2021 |
| Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant P Mlcochova, D Collier, A Ritchie, SM Assennato, M Hosmillo, N Goel, ... Cell Reports Medicine 1 (6), 2020 | 84 | 2020 |
| Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19 NK Jones, L Rivett, D Sparkes, S Forrest, S Sridhar, J Young, ... Elife 9, e59391, 2020 | 78 | 2020 |
| B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination P Kotagiri, F Mescia, WM Rae, L Bergamaschi, ZK Tuong, L Turner, ... Cell reports 38 (7), 2022 | 35 | 2022 |
| SARS-CoV-2 Omicron spike mediated immune escape and tropism shift B Meng, IATM Ferreira, A Abdullahi, N Goonawardane, A Saito, I Kimura, ... BioRxiv, 2021.12. 17.473248, 2021 | 35 | 2021 |
| HCMV antivirals and strategies to target the latent reservoir MR Perera, MR Wills, JH Sinclair Viruses 13 (5), 817, 2021 | 29 | 2021 |
| SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity B Meng, R Datir, J Choi, S Baker, G Dougan, C Hess, N Kingston, ... Cell Reports 40 (7), 2022 | 26 | 2022 |
| Regulation of host and viral promoters during human cytomegalovirus latency via US28 and CTCF EG Elder, BA Krishna, E Poole, M Perera, J Sinclair Journal of General Virology 102 (5), 001609, 2021 | 15 | 2021 |
| Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups L Hurler, Á Szilágyi, F Mescia, L Bergamaschi, B Mező, G Sinkovits, ... Frontiers in immunology 14, 1162171, 2023 | 12 | 2023 |
| Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs L Hurler, EJM Toonen, E Kajdácsi, B van Bree, RJ Brandwijk, W de Bruin, ... Frontiers in immunology 13, 1039765, 2022 | 11 | 2022 |
| A BMPR2/YY1 signaling axis is required for human cytomegalovirus latency in undifferentiated myeloid cells E Poole, MC Carlan da Silva, C Huang, M Perera, S Jackson, IJ Groves, ... MBio 12 (3), 10.1128/mbio. 00227-21, 2021 | 11 | 2021 |
| Human cytomegalovirus infection of epithelial cells increases SARS-CoV-2 superinfection by upregulating the ACE2 receptor MR Perera, EJD Greenwood, TWM Crozier, EG Elder, J Schmitt, ... The Journal of infectious diseases 227 (4), 543-553, 2023 | 10 | 2023 |
| Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly IATM Ferreira, CYC Lee, WS Foster, A Abdullahi, LM Dratva, ZK Tuong, ... Cell Reports 42 (8), 2023 | 6 | 2023 |
Dr M.R. WillsUniversity of CambridgeVerified email at cam.ac.uk
